Copyright Reports & Markets. All rights reserved.

Global Women's Health Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Women's Health by Type
    • 1.3.1 Overview: Global Women's Health Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Women's Health Consumption Value Market Share by Type in 2024
    • 1.3.3 Hormone Therapy
    • 1.3.4 Nonhormonal Therapy
  • 1.4 Global Women's Health Market by Application
    • 1.4.1 Overview: Global Women's Health Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Climacteric
    • 1.4.3 Postmenopausal Osteoporosis
    • 1.4.4 Contraceptive Pill
    • 1.4.5 Infertility
    • 1.4.6 Others
  • 1.5 Global Women's Health Market Size & Forecast
  • 1.6 Global Women's Health Market Size and Forecast by Region
    • 1.6.1 Global Women's Health Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Women's Health Market Size by Region, (2020-2031)
    • 1.6.3 North America Women's Health Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Women's Health Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Women's Health Market Size and Prospect (2020-2031)
    • 1.6.6 South America Women's Health Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Women's Health Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Amgen
    • 2.1.1 Amgen Details
    • 2.1.2 Amgen Major Business
    • 2.1.3 Amgen Women's Health Product and Solutions
    • 2.1.4 Amgen Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Amgen Recent Developments and Future Plans
  • 2.2 Bayer
    • 2.2.1 Bayer Details
    • 2.2.2 Bayer Major Business
    • 2.2.3 Bayer Women's Health Product and Solutions
    • 2.2.4 Bayer Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Bayer Recent Developments and Future Plans
  • 2.3 Merck KGaA
    • 2.3.1 Merck KGaA Details
    • 2.3.2 Merck KGaA Major Business
    • 2.3.3 Merck KGaA Women's Health Product and Solutions
    • 2.3.4 Merck KGaA Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Merck KGaA Recent Developments and Future Plans
  • 2.4 Merck & Co
    • 2.4.1 Merck & Co Details
    • 2.4.2 Merck & Co Major Business
    • 2.4.3 Merck & Co Women's Health Product and Solutions
    • 2.4.4 Merck & Co Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Merck & Co Recent Developments and Future Plans
  • 2.5 Ferring
    • 2.5.1 Ferring Details
    • 2.5.2 Ferring Major Business
    • 2.5.3 Ferring Women's Health Product and Solutions
    • 2.5.4 Ferring Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Ferring Recent Developments and Future Plans
  • 2.6 Eli Lilly
    • 2.6.1 Eli Lilly Details
    • 2.6.2 Eli Lilly Major Business
    • 2.6.3 Eli Lilly Women's Health Product and Solutions
    • 2.6.4 Eli Lilly Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Eli Lilly Recent Developments and Future Plans
  • 2.7 Pfizer
    • 2.7.1 Pfizer Details
    • 2.7.2 Pfizer Major Business
    • 2.7.3 Pfizer Women's Health Product and Solutions
    • 2.7.4 Pfizer Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Pfizer Recent Developments and Future Plans
  • 2.8 AbbVie
    • 2.8.1 AbbVie Details
    • 2.8.2 AbbVie Major Business
    • 2.8.3 AbbVie Women's Health Product and Solutions
    • 2.8.4 AbbVie Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 AbbVie Recent Developments and Future Plans
  • 2.9 Abbott
    • 2.9.1 Abbott Details
    • 2.9.2 Abbott Major Business
    • 2.9.3 Abbott Women's Health Product and Solutions
    • 2.9.4 Abbott Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Abbott Recent Developments and Future Plans
  • 2.10 Theramex
    • 2.10.1 Theramex Details
    • 2.10.2 Theramex Major Business
    • 2.10.3 Theramex Women's Health Product and Solutions
    • 2.10.4 Theramex Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Theramex Recent Developments and Future Plans
  • 2.11 Livzon Pharmaceuticals
    • 2.11.1 Livzon Pharmaceuticals Details
    • 2.11.2 Livzon Pharmaceuticals Major Business
    • 2.11.3 Livzon Pharmaceuticals Women's Health Product and Solutions
    • 2.11.4 Livzon Pharmaceuticals Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Livzon Pharmaceuticals Recent Developments and Future Plans
  • 2.12 Foundation Consumer Healthcare
    • 2.12.1 Foundation Consumer Healthcare Details
    • 2.12.2 Foundation Consumer Healthcare Major Business
    • 2.12.3 Foundation Consumer Healthcare Women's Health Product and Solutions
    • 2.12.4 Foundation Consumer Healthcare Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Foundation Consumer Healthcare Recent Developments and Future Plans
  • 2.13 Xianjun Pharmaceuticals
    • 2.13.1 Xianjun Pharmaceuticals Details
    • 2.13.2 Xianjun Pharmaceuticals Major Business
    • 2.13.3 Xianjun Pharmaceuticals Women's Health Product and Solutions
    • 2.13.4 Xianjun Pharmaceuticals Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Xianjun Pharmaceuticals Recent Developments and Future Plans
  • 2.14 Zizhu Pharmaceuticals
    • 2.14.1 Zizhu Pharmaceuticals Details
    • 2.14.2 Zizhu Pharmaceuticals Major Business
    • 2.14.3 Zizhu Pharmaceuticals Women's Health Product and Solutions
    • 2.14.4 Zizhu Pharmaceuticals Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Zizhu Pharmaceuticals Recent Developments and Future Plans
  • 2.15 Qianjin Pharmaceuticals
    • 2.15.1 Qianjin Pharmaceuticals Details
    • 2.15.2 Qianjin Pharmaceuticals Major Business
    • 2.15.3 Qianjin Pharmaceuticals Women's Health Product and Solutions
    • 2.15.4 Qianjin Pharmaceuticals Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Qianjin Pharmaceuticals Recent Developments and Future Plans
  • 2.16 Organon Pharma
    • 2.16.1 Organon Pharma Details
    • 2.16.2 Organon Pharma Major Business
    • 2.16.3 Organon Pharma Women's Health Product and Solutions
    • 2.16.4 Organon Pharma Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Organon Pharma Recent Developments and Future Plans
  • 2.17 Insud Pharma
    • 2.17.1 Insud Pharma Details
    • 2.17.2 Insud Pharma Major Business
    • 2.17.3 Insud Pharma Women's Health Product and Solutions
    • 2.17.4 Insud Pharma Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Insud Pharma Recent Developments and Future Plans
  • 2.18 Viatris
    • 2.18.1 Viatris Details
    • 2.18.2 Viatris Major Business
    • 2.18.3 Viatris Women's Health Product and Solutions
    • 2.18.4 Viatris Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Viatris Recent Developments and Future Plans
  • 2.19 Teva
    • 2.19.1 Teva Details
    • 2.19.2 Teva Major Business
    • 2.19.3 Teva Women's Health Product and Solutions
    • 2.19.4 Teva Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 Teva Recent Developments and Future Plans
  • 2.20 Hisamitsu
    • 2.20.1 Hisamitsu Details
    • 2.20.2 Hisamitsu Major Business
    • 2.20.3 Hisamitsu Women's Health Product and Solutions
    • 2.20.4 Hisamitsu Women's Health Revenue, Gross Margin and Market Share (2020-2025)
    • 2.20.5 Hisamitsu Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Women's Health Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Women's Health by Company Revenue
    • 3.2.2 Top 3 Women's Health Players Market Share in 2024
    • 3.2.3 Top 6 Women's Health Players Market Share in 2024
  • 3.3 Women's Health Market: Overall Company Footprint Analysis
    • 3.3.1 Women's Health Market: Region Footprint
    • 3.3.2 Women's Health Market: Company Product Type Footprint
    • 3.3.3 Women's Health Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Women's Health Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Women's Health Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Women's Health Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Women's Health Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Women's Health Consumption Value by Type (2020-2031)
  • 6.2 North America Women's Health Market Size by Application (2020-2031)
  • 6.3 North America Women's Health Market Size by Country
    • 6.3.1 North America Women's Health Consumption Value by Country (2020-2031)
    • 6.3.2 United States Women's Health Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Women's Health Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Women's Health Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Women's Health Consumption Value by Type (2020-2031)
  • 7.2 Europe Women's Health Consumption Value by Application (2020-2031)
  • 7.3 Europe Women's Health Market Size by Country
    • 7.3.1 Europe Women's Health Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Women's Health Market Size and Forecast (2020-2031)
    • 7.3.3 France Women's Health Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Women's Health Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Women's Health Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Women's Health Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Women's Health Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Women's Health Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Women's Health Market Size by Region
    • 8.3.1 Asia-Pacific Women's Health Consumption Value by Region (2020-2031)
    • 8.3.2 China Women's Health Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Women's Health Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Women's Health Market Size and Forecast (2020-2031)
    • 8.3.5 India Women's Health Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Women's Health Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Women's Health Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Women's Health Consumption Value by Type (2020-2031)
  • 9.2 South America Women's Health Consumption Value by Application (2020-2031)
  • 9.3 South America Women's Health Market Size by Country
    • 9.3.1 South America Women's Health Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Women's Health Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Women's Health Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Women's Health Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Women's Health Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Women's Health Market Size by Country
    • 10.3.1 Middle East & Africa Women's Health Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Women's Health Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Women's Health Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Women's Health Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Women's Health Market Drivers
  • 11.2 Women's Health Market Restraints
  • 11.3 Women's Health Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Women's Health Industry Chain
  • 12.2 Women's Health Upstream Analysis
  • 12.3 Women's Health Midstream Analysis
  • 12.4 Women's Health Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Women's Health market size was valued at US$ 36140 million in 2024 and is forecast to a readjusted size of USD 47260 million by 2031 with a CAGR of 3.8% during review period.
    Women's health refers to the branch of healthcare that focuses on the unique medical needs of women throughout different stages of life, from puberty to menopause and beyond. It includes a wide range of conditions and treatments related to reproductive health, hormonal imbalances, pregnancy, breast health, osteoporosis, and mental well-being. Women's health also covers issues like sexual health, contraception, fertility, and gynecological diseases such as endometriosis and polycystic ovary syndrome (PCOS). Recognizing that women experience health issues differently than men, this field emphasizes gender-specific research and treatments tailored to the physiological, psychological, and social needs of women.
    Market Driver: The increasing focus on women’s health, driven by a combination of greater awareness, advocacy, and healthcare advancements, is a major driver of the women’s health market. As women continue to seek more personalized and comprehensive care, demand for treatments addressing conditions like reproductive health, menopause, osteoporosis, breast cancer, and mental health is on the rise. This is further supported by the growing recognition of the need for gender-specific healthcare solutions, including pharmaceuticals, diagnostics, and wellness products. Additionally, the rise in women’s life expectancy and the increasing number of women in the workforce who are able to access healthcare resources have also contributed to the growth of this market.
    Market Challenge: Despite the growing demand for women’s health products and services, the market faces several challenges, including underrepresentation of women in clinical research and the lack of tailored treatments for gender-specific health issues. Many medical studies have historically been conducted with a male-dominated sample, which leads to insufficient data on how treatments affect women differently. Moreover, there are still significant social and cultural barriers in certain regions that prevent women from accessing adequate healthcare or seeking treatments for issues like reproductive health or menopause. These challenges can slow market growth, limit access, and hinder the development of more effective and personalized care for women.
    The main companies of Global Women's Health include Amgen, Bayer, Merck KGaA, etc. These top three companies hold a market share about 20%. Europe and North America are the leading production regions in the world. The product is mainly used in contraceptive pills.
    This report is a detailed and comprehensive analysis for global Women's Health market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Women's Health market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Women's Health market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Women's Health market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Women's Health market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Women's Health
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Women's Health market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Bayer, Merck KGaA, Merck & Co, Ferring, Eli Lilly, Pfizer, AbbVie, Abbott, Theramex, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Women's Health market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Hormone Therapy
    Nonhormonal Therapy
    Market segment by Application
    Climacteric
    Postmenopausal Osteoporosis
    Contraceptive Pill
    Infertility
    Others
    Market segment by players, this report covers
    Amgen
    Bayer
    Merck KGaA
    Merck & Co
    Ferring
    Eli Lilly
    Pfizer
    AbbVie
    Abbott
    Theramex
    Livzon Pharmaceuticals
    Foundation Consumer Healthcare
    Xianjun Pharmaceuticals
    Zizhu Pharmaceuticals
    Qianjin Pharmaceuticals
    Organon Pharma
    Insud Pharma
    Viatris
    Teva
    Hisamitsu
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Women's Health product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Women's Health, with revenue, gross margin, and global market share of Women's Health from 2020 to 2025.
    Chapter 3, the Women's Health competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Women's Health market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Women's Health.
    Chapter 13, to describe Women's Health research findings and conclusion.

    Buy now